Career history of Edward D. Wirth
Former positions of Edward D. Wirth
| Companies | Position | Start | End |
|---|---|---|---|
| ASTERIAS BIOTHERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 2013-02-28 | 2019-02-28 |
| Corporate Officer/Principal | 2013-02-28 | 2015-05-25 | |
InVivo Therapeutics Corp.
 InVivo Therapeutics Corp. BiotechnologyHealth Technology InVivo Therapeutics Corp. operates as a medical device company that develops groundbreaking technologies for the treatment of spinal cord injuries. The company was founded by Joseph P. Vacanti and Robert S. Langer, Jr. in 2005 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2011-12-31 | 2012-08-31 |
| GERON CORPORATION | Corporate Officer/Principal | 2010-12-31 | 2011-09-30 |
| LINEAGE CELL THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-02-28 | - |
Training of Edward D. Wirth
| University of Florida | Doctorate Degree |
Statistics
International
| United States | 6 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
| GERON CORPORATION | Health Technology |
| Private companies | 2 |
|---|---|
InVivo Therapeutics Corp.
InVivo Therapeutics Corp. BiotechnologyHealth Technology InVivo Therapeutics Corp. operates as a medical device company that develops groundbreaking technologies for the treatment of spinal cord injuries. The company was founded by Joseph P. Vacanti and Robert S. Langer, Jr. in 2005 and is headquartered in Cambridge, MA. | Health Technology |
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
- Stock Market
- Insiders
- Edward D. Wirth
- Experience
